Protagonist Therapeutics to Host Conference Call to Announce an Oral Obesity Development Candidate

Monday, June 30th at 4:30 pm ET

US-based Investors: 1-877-407-0752

International Investors: 1-201-389-0912

Conference Call ID: 13754335

WEBCAST